Department of Clinical Chemistry
University of Turku

Back to the main page of the Department of Clinical Chemistry

Julkaisut 2000 / Publications in 2000

Väitöskirjat / Dissertations

  1. Ahokoski O: Pharmacokinetics and pharmacodynamics of finrozole, a novel aromatase inhibitor, in healthy male subjects. Annales Universitatis Turkuensis Ser D, Tom 406. 117 sivua. Turun yliopisto 2000.

  2.  Saaresranta T: Effect of medroxyprogesterone acetate on breathing and sleep in postmenopausal women with chronic respiratory failure or partial upper airway obstruction during sleep. Annales Universitatis Turkuensis Ser D, Tom 422. 229 sivua. Turun yliopisto 2000.

  3.  Suominen P: Serum transferrin receptor: Methods and clinical applications in staging and detection of iron deficiency. Annales Universitatis Turkuensis Ser D, Tom 397. 100 sivua. Turun yliopisto 2000.

Väitöskirjojen myyntijakelu: Turun yliopiston kirjasto, 20500 TURKU
puh. 02-6336170, fax 02-6335050, telex: 62163 Tyk FI

Distributor of the Dissertations: Turku University Library, FIN-20500 TURKU
tel. +358-2-6336170, fax +358-2-6335050, telex: 62163 Tyk FI

 

Muut julkaisut / Other publications

 

  1. Arojoki M, Jokimaa V, Juuti A, Koskinen P, Irjala K, Anttila L: Hypothyroidism among infertile women in Finland. Gynecol Endocrinol 14:127-131, 2000. [C]
  2. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM: Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60:1789-1792, 2000. [C]
  3. *Arkkila PE, Koskinen PJ, Kantola IM, Rönnemaa T, Seppänen E, Viikari JS: Dupuytren´s disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagen. Clin Exp Rheumatol 18:215-219, 2000. [C]
  4. Donohoe GG, Laaksonen M, Pulkki K, Rönnemaa T, Kairisto V: Rapid single-tube screening of C282Y hemochromatosis mutation by real time multiplex allele-specific PCR without fluorescent probes. Clin Chem 46:1540-1547, 2000. [C]
  5. *Dunder U, *Kaartinen V, *Valtonen P, *Väänänen E, *Kosma V-M, *Heisterkamp N, *Groffen J, Mononen I: Enzyme replacement therapy in a mouse model of aspartylglycosaminuria. The FASEB Journal 14:361-367, 2000. [C]
  6. Forsström J: Lääketieteen tietopalvelut verkossa. Kirjassa: Voipio-Pulkki, Grénman, Haapamäki ym. (toim.): Kliinisen tutkijan opas. Kustannus Oy Duodecim 2000. ss. 195-203. [d]
  7. Forsström J: Makropilotin Elektroninen lääkemääräys -osahanke. Lääkepäivät: Farmasia tietoyhteiskunnassa. Kuopio 24.3. ss. 31-36. [i]
  8. Forsström J: Remote electronic knowledge bases and information services: their compilation and quality assurance. In: Rigby M, Roberts R, Thick M (eds.): Taking Health Telematics in the 21st Centure. Radcliff Medical Press, Oxon, U.K., 2000. ss. 51-60. [D]
  9. Forsström J: Virtuaalinen terveydenhuolto EU:n alueella. Lääkepäivät: Farmasia tietoyhteiskunnassa. Kuopio 24.3. ss. 22-30. [i]
  10. Forsström J, *Rigby M: TEAC-Health - Research-based recommendations for European certification of Health Telematics services. Medical Informatics for Europe MIE 2000, Hannover. Hasman A et al. (eds.) IOS Press. 2000. ss. 288-292. [D]
  11. Grönroos P, Vanharanta R, Rajamäki A: Advia TM120-verenkuva-analysaattorin koestus. KliinLab 1:10-14, 2000. [c]
  12. Hämäläinen M, *Eskola U, Hellman J: Menetelmä elimistönestenäytteen käsittelemiseksi RNA-analysointiin soveltuvaksi. Patentti no. 105049, 2000. [k]
  13. Hämäläinen MM, *Eskola JU, Hellman J, Pulkki K, Rajamäki A: RT-PCR from eosinphil-depleted leukocytes without RNA extraction: Cell selection using streptavidin PCR tubes. J Clin Biochem 33:643-647, 2000. [C]
  14. Kailajärvi M, Ahokoski O, *Virtanen A, Salminen E, Irjala K: Alterations in laboratory test results during adjuvant breast cancer treatment. Clin Chem Lab Med 38:443-451, 2000. [C]
  15. Kailajärvi M, Ahokoski O, *Virtanen A, Salminen E, Irjala K: Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids. Anticancer Res 20:1323-1328, 2000. [C]
  16. Kailajärvi M, Takala T, Grönroos P, *Tryding N, Viikari J, Irjala K, Forsström J: Reminders of drug effects on laboratory test results. Clin Chem 46:1395-1400, 2000. [C]
  17. Kairisto V, Pelliniemi T-T, Grönroos P, Hämäläinen M, Rajamäki A: Minimal residual disease quantification in acute lymphoblastic leukemia by real-time PCR using patient specific primers and melting curve analysis. Blood 96:192b(4546), 2000. Abstracts for the 42nd Annual Meeting of the American Society of Hematology, San Francisco 1.-5.12.2000. [D]
  18. Kauppila M, Koskinen P, Pulkki K, Sonninen P, Remes K, Irjala K, Viikari J: Interferon-alpha treatment decreases serum cross-linked C-terminal telopeptide of type I collagen in haematological diseases. Clin Lab Haematol 22:15-20, 2000. [C]
  19. Kiviniemi M, Sauroja I, Rajamäki A, Punnonen K, Söderström K-O, Salminen E: Cell cycle regulators p27 and pRb in lymphomas - correlation with histology and proliferative activity. Br J Cancer 83:1161-1167, 2000. [C]
  20. *Knekt P, *Hakulinen A, Leino A, Heliövaara M, Reunanen A, Stevens R: Serum albumin and colorectal cancer. Eur J Clin Nutr 54:460-462, 2000. [C]
  21. *Koistinen PO, *Rusko H, Irjala K, Rajamäki A, *Penttinen K, *Sarparanta V-P, *Karpakka J, *Leppäluoto J: EPO, red cells, and serum transferrin receptor in continuous and intermittent hypoxia. Med Sci Sports Exerc 32:800-804, 2000. [C]
  22. Koskela K, Pelliniemi T-T, Rajamäki A, Pulkki K, Remes K: Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis. Eur J Haematol 65:52-56, 2000. [C]
  23. Koskinen P: Glukoosimääritysten preanalytiikka. Moodi 24:176-178, 2000. [c]
  24. Lahti A, Kairisto V: Pohjoismaisen viitearvoprojektin tilannekatsaus. KliinLab 17:60-64, 2000. [e]
  25. Laine H, Nuutila P, Luotolahti M, Meyer C, Elomaa T, Koskinen P, Rönnemaa T, Knuuti J: Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. J Clin Encrinol Metab 85:1868-1873, 2000. [C]
  26. Laine K, Forsström J, Grönroos P, Irjala K, Kailajärvi M, Scheinin M: Frequency and clinical outcome of potentially harmful metabolic drug interactions in patients hospitalized on internal and pulmonary medicine wards: Focus on warfarin and cisapride. Ther Drug Monit 22:503-509, 2000. [C]
  27. Laine VOJ, Rajamäki A, *Grass DS, Nevalainen T: Neutrophil response of transgenic mice expressing human group IIA Phospholipase A2 in bacterial infections. Scand J Immunol 52:362-368, 2000. [C]
  28. Lehtonen-Veromaa M, Möttönen T, Irjala K, Nuotio I, Leino A, Viikari J: A 1-year prospective study on the relationship between physical activity, markers of bone metabolism and bone acquisition in peripubertal girls. J Clin Endocrinol Metab 85:3726-3732, 2000. [C]
  29. Lehtonen-Veromaa M, Möttönen T, Nuotio I, Irjala K, Viikari J: The association of serum 25-hydroxyvitamin D with bone acquisition among peripubertal Finnish girls: A 12-month prospective study. Scand J Rheumatol 29(Suppl 114):P107. Abstracts from the 28th Scandinavian Congress of Rheumatology, Turku, Finland 7.-10.9.2000. [d]
  30. Lukkarinen M, Näntö-Salonen K, Pulkki K, Mattila K, Simell O: Effect of lysine infusion on urea cycle in lysinuric protein intolerance. Metabolism 49:621-625, 2000. [C]
  31. *Luukkaa V, *Rouru J, Ahokoski O, Scheinin H, Irjala K, Huupponen R: Acute inhibition of oestrogen biosynthesis does not affect serum leptin levels in young men. Eur J Endocrinol 142:164-169, 2000. [C]
  32. Nyrhinen T, Leino-Kilpi H: Ethics in the laboratory examination of patients. J Med Ethics 26:54-60, 2000. [C]
  33. *Oivanen T, *Ala-Harja A, *Almqvist A, *Apajalahti J, *Elonen E, *Hallman H, *Hänninen A, *Ilvonen M, *Isomaa B, *Jouppila J, *Järvenpää E, *Järventie G, *Kilpi H, *Koistinen P, *Koistinen S, *Koivisto A-M, *Koivunen E, *Korpi E, Kätkä K, *Kääriäinen M, *Lahtinen R, *Laitinen A, *Lehtinen M, *Mäkela H, *Hyländen P, *Nyman D, *Palva I, Pelliniemi T-T, *Pulli T, Rajamäki A, *Rauhala A, Remes K, *Rosengård S, *Ruutu T, *Soininen K, *Tiilikainen J, *Timonen T, *Waris E, *Vilpo J, *Volin L (The Finnish Leukaemia Group): Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study. Eur J Haematol 65:123-127, 2000. [C]
  34. Pajulo OT, Lertola KK, Pulkki KJ, *Vuorio HK, Sivula SM, Viljanto JA: Wound cell variation in closed surgical wounds as measured with two independent methods. Ann Chir Gynaecol Fe 89:107-111, 2000. [C]
  35. Pajulo OT, Pulkki KJ, Alanen MS, Reunanen MS, Lertola KK, Mattila-Vuori AI, Viljanto JA: Duration of surgery and patient age affect wound healing in children. Wound Repair Regen 8:174-178, 2000. [C]
  36. Pelliniemi T-T: Kroonisen lymfaattisen leukemian erotusdiagnostiikka. Suomen Lääkärilehti 23: 2527-2532, 2000. [e]
  37. Peltola K, Heinonen OJ, Näntö-Salonen K, Pulkki K, Simell O: Oral lysine feeding in gyrate atrophy with hyperornithinaemia--a pilot study. J Inherit Metab Dis 23:305-307, 2000. [C]
  38. Peltola O: Seerumia vai plasmaa? Moodi 2:60-62, 2000. [C]
  39. Pietilä M, *Malminiemi K, Huupponen R, Rouru J, Pulkki K, Pere E, Voipio-Pulkki L-M: Celiprolol augments the effects of physical exercise on insulin sensitivity and serum lipid levels in chronic heart failure. European Journal of Heart Failure 2:81-90, 2000. [C]
  40. Porela P, Helenius H, Pulkki K, Peltola O, Hänninen K-P, Pettersson K, Wacker M, Voipio-Pulkki L-M: Cardiac decompensation during an ischemic event weakens the predictive power of myocardial injury markers. Clin Chim Acta 302:133-44, 2000. [C]
  41. Porela P, Pulkki K, Helenius H, Antila KJ, Pettersson K, Wacker M, Voipio-Pulkki L-M: Prediction of short-term outcome in patients with suspected myocardial infarction. Ann Emerg Med 35:413-420, 2000. [C]
  42. Porela P, Pulkki K, Voipio-Pulkki L-M, Pettersson K, Leppänen V, Nevalainen T: Levels of circulating phospholipase A2 in prediction of the prognosis of patients with suspected myocardial infarction. Basic Res Cardiol 95:413-417, 2000. [C]
  43. Raitakari M, *Brown RD, *Sze D, *Yuen E, *Barrow L, *Nelson M, *Pope B, *Esdale W, *Gibson J, *Joshua DE: T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells. Brit J Haematol 110:203-209, 2000. [C]
  44. Roine R, Forsström J: Terveydenhuollon menetelmien arviointi. Kirjassa: Voipio-Pulkki, Grénman, Haapamäki ym. (toim.): Kliinisen tutkijan opas. Kustannus Oy Duodecim 2000. ss. 89-98. [d]
  45. Rintala E, Peuravuori H, Pulkki K, Voipio-Pulkki LM, Nevalainen T: Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome. Intensive Care Med 26:1248-1251, 2000. [C]
  46. *Romppanen E-L, Mononen I: Detection of the Finnish-type congenital nephrotic syndrome by restriction fragment length polymorphism and dual-color oligonucleotide ligation assay. Clin Chem 46:811-816, 2000. [C]
  47. *Romppanen E-L, *Savolainen K, Mononen I: Optimal use of the fluorescent PicoGreen dye for quantitative analysis of amplified polymerase chain reaction products on microplate. Anal Biochem 279:111-114, 2000. [C]
  48. *Räty R, *Virtanen A, Koskinen P, *Laitinen P, Forsström J, *Salonen R, *Mörsky P, Ekblad U: Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies. Prenat Diagn 20:221-223, 2000. [C]
  49. Rönnemaa T, Pulkki K, Kaprio J: Serum Soluble Tumor Necrosis Factor-a Receptor 2 is elevated in obesity but not related to insulin sensitivity: A study in identical twins discordant for obesity. J Clin Endocrinol Metab 85:2728-2732, 2000. [C]
  50. Saaresranta T, Irjala K, Polo-Kantola P, Helenius H, Polo O: IGF-I and ventilation after short-term progestin in postmenopausal women with chronic respiratory insufficiency. Respir Med 94:909-916, 2000. [C]
  51. Saaresranta T, Irjala K, Polo-Kantola P, Helenius H, Polo O: Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiency. Obstet Gynecol 96:243-249, 2000. [C]
  52. Salo P, Viikari J, Hämäläinen M, Lapinleimu H, Routi T, Niinikoski H, Rask-Nissilä L, Tammi A, Rönnemaa T, Seppänen R, Jokinen E, Välimäki I, Simell O: Fatty acid composition of serum cholesterol esters as a reflector of low-saturated-fat, low-cholesterol diet in young children: the STRIP project. Acta Paediatrica 89:399-405, 2000. [C]
  53. Saraste A, Pulkki K: Morphological and biochemical hallmarks of apoptosis. Cardiovascular Res 45: 528-535, 2000. [C]
  54. Saraste A, Pulkki K, Voipio-Pulkki L-M: Apoptosis in dilated cardiomyopathy. Circulation 101:e239, 2000. [C]
  55. Suominen P, Möttönen T, Rajamäki A, Irjala K: Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 43:1016-1020, 2000. [C]
  56. Tammi A, Rönnemaa T, *Gylling H, *Rask-Nissilä L, Viikari J, Tuominen J, Pulkki K, Simell O: A randomised double-blind cross-over study of plant stanol margarine in healthy 6-year old children already consuming a low-saturated fat, low-cholesterol diet: The STRIP project. J Pediat 136:503-510, 2000. [C]
  57. Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, Ruuskanen O: Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 19:598-602, 2000. [C]
  58. *Vasankari T, Lehtonen-Veromaa M, Möttönen T, Ahotupa M, Irjala K, *Heinonen O, Leino A, Viikari J: Reduced mildly oxidized LDL in young female athletes. Atherosclerosis 151:399-405, 2000. [C]
  59. *Välimäki M, *Alhava E, *Hirvonen E, Irjala K, *Kröger H, *Lamberg-Allardt C, *Myllynen P, *Salmi J, *Sane T, *Suominen H, Viikari J, Väänänen K: Osteoporoosi. Käypä hoito -suositus. Duodecim 116:1772-1788, 2000. [c]
  60. *Ylikangas P, Mononen I: A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy. Anal Biochem 280:42-45, 2000. [C]

Aiemmin ilmoittamattomia:

*Oivanen T, *Ala-Harja A, *Almqvist A, *Apajalahti J, *Elonen E, *Hallman H, *Hänninen A, *Ilvonen M, *Isomaa B, *Jouppila J, *Järvenpää E, *Järventie G, *Kilpi H, *Koistinen P, *Koistinen S, *Koivisto A-M, *Koivunen E, *Korpi E, Kätkä K, *Kääriäinen M, *Lahtinen R, *Laitinen A, *Lehtinen M, *Mäkela H, *Hyländen P, *Nyman D, *Palva I, Pelliniemi T-T, *Pulli T, Rajamäki A, *Rauhala A, Remes K, *Rosengård S, *Ruutu T, *Soininen K, *Tiilikainen J, *Timonen T, *Waris E, *Vilpo J, *Volin L (The Finnish Leukaemia Group): Long-term survival in multiple myeloma: a Finnish Leukaemia Group Study. Br J Haematol 105:942-947, 1999 [C]